Reply to Letter by Akboga et al Entitled "Are Endocan and Ischemia-Modified Albumin Reliable Biomarkers for Endothelial Dysfunction in Type 2 Diabetes Mellitus?". (May 2020)

Record Type:: Journal Article
Title:: Reply to Letter by Akboga et al Entitled "Are Endocan and Ischemia-Modified Albumin Reliable Biomarkers for Endothelial Dysfunction in Type 2 Diabetes Mellitus?". (May 2020)
Main Title:: Reply to Letter by Akboga et al Entitled "Are Endocan and Ischemia-Modified Albumin Reliable Biomarkers for Endothelial Dysfunction in Type 2 Diabetes Mellitus?"
Authors:: Balamir, Ilhan
Ates, Ihsan
Topcuoglu, Canan
Turhan, Turan
Abstract:
Is Part Of:: Angiology. Volume 71:Number 5(2020)
Journal:: Angiology
Issue:: Volume 71:Number 5(2020)
Issue Display:: Volume 71, Issue 5 (2020)
Year:: 2020
Volume:: 71
Issue:: 5
Issue Sort Value:: 2020-0071-0005-0000
Page Start:: 481
Page End:: 481
Publication Date:: 2020-05
Subjects:: Blood-vessels -- Diseases -- Periodicals
Cardiovascular system -- Diseases -- Periodicals
616.13005
Journal URLs:: http://ang.sagepub.com ↗
http://firstsearch.oclc.org ↗
http://galenet.galegroup.com/servlet/HWRC?locID=lcml_main ↗
http://www.sagepublications.com/ ↗
DOI:: 10.1177/0003319718793784 ↗
Languages:: English
ISSNs:: 0003-3197
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 13071.xml